What is Spinal Muscular Atrophy (SMA)?
Spinal muscular atrophy (SMA) is a rare genetic disease in which some nerve cells in the spinal cord are affected, causing muscle weakness.
Spinal muscular atrophy (SMA) is a rare genetic disease in which some nerve cells in the spinal cord are affected, causing muscle weakness. This happens because the specific nerve cells in the body that control muscle movement, called motor neurons, deteriorate and stop working.
SMA affects approximately 1 in 10,000/12,000 babies born and can affect any race or gender without distinction. More than 1 in 58 people are carriers of the disease mutation.
What causes SMA?
The survival motor neuron (SMN) protein is vital for motor neurons to function properly. Without the SMN protein, the motor neurons in the spinal cord stop working and the muscles weaken.
In SMA, the main SMN gene, known as SMN1, is defective or missing. There is a second gene, known as SMN2, which acts more like a "boost" and only produces small amounts of SMN protein.
In SMA, not enough SMN protein is made and motor neurons stop working, causing muscles to become weaker.
What is the cause of SMA?
SMA is usually hereditary, although it can occasionally be caused by a random error in the SMN1 gene.(corti lab)
Babies inherit two copies of the SMN1 gene, one from each parent. People with one healthy and one defective SMN1 gene are known as carriers, and they usually show no symptoms of SMA.
If both parents are carriers, there is a 25% chance that the baby will inherit and develop SMA.
SMA is a rapidly progressing disease, so every day counts. Its early detection is vital so that the baby receives medical attention as soon as possible and to slow down the progress of the disease. For this reason, it is very important to be attentive to the early signs of the pathology. For all the complete information on the symptoms of SMA, consult https://www.cortilab.org/
The global spinal muscular atrophy (SMA) treatment market size is expected to reach USD 14.49 billion by 2026, exhibiting a CAGR of 28.9% during the forecast period.
The rising prevalence of rare diseases around the world will fuel demand for SMA treatment in the forthcoming years, which in turn will aid the growth of the market.
As per the National Policy for the treatment of rare diseases, globally, around 6000 to 8000 rare diseases are estimated to exist with new rare diseases reported on a regular basis.
Furthermore, 80% of all the rare diseases are genetically originated and therefore impact children inexplicably.
Nonetheless, “the growing initiatives by government authorities for pre-diagnosis will impact the spinal muscular atrophy (SMA) treatment market share positively during the forecast period”, predicts our lead analysts at Fortune Business Insights.Market Driver: R Initiatives by Key Players to Spur Sales Opportunities The surge in research and development activities for the improvement of therapies and treatment options by key players will aid the spinal muscular atrophy (SMA) treatment market growth during the forecast period.
Furthermore, the growing initiatives for pre-diagnosis and positive reimbursement policies will boost the spinal muscular atrophy (SMA) treatment market trends in the foreseeable future.
Spinal Muscular Atrophy (SMA) Treatment Market report added by Value Market Research, offering growth, trends, and forecast for each segment along with regional and country analysis.
Further, this report also highlights the regional and country-level market analysis.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.
An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Spinal Muscular Atrophy (SMA) Treatment Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/spinal-muscular-atrophy-sma-treatment-market/download-sampleMarket DynamicsThe increasing awareness by various NGO’s and the public regarding Spinal Muscular Atrophy (SMA) and a growing number of initiatives to improve treatment for rare diseases are fueling the market growth of SMA treatment.
Moreover, improving the healthcare sector is again boosting the market growth.
Whereas, innovation of more efficient drugs and therapies is expected to offer opportunities to SMA treatment market in the forecast period.This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis.
These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities.
